Related Experiment Video
Updated: May 25, 2026
12:09
Transient Expression and Cellular Localization of Recombinant Proteins in Cultured Insect Cells
Published on: April 20, 2017
Recombinant protein vaccines produced in insect cells
1Protein Sciences Corporation, 1000 Research Parkway, Meriden, CT 06450, USA. manon.cox@proteinsciences.com
Vaccine
|January 24, 2012
Summary
The baculovirus-insect cell expression system offers a versatile platform for producing diverse protein-based vaccines. This technology enables cost-effective manufacturing of human and veterinary vaccines, adaptable for pandemic response.
Area of Science:
- Biotechnology
- Vaccinology
- Protein Expression
Background:
- The baculovirus-insect cell expression system is established for complex protein production.
- This technology is utilized in the commercial manufacturing of human and veterinary vaccines.
Purpose of the Study:
- To review the application of baculovirus-insect cell technology for producing various vaccine candidates.
- To highlight the potential for a universal "plug and play" manufacturing process for protein-based vaccines.
Main Methods:
- Review of existing literature and case studies on baculovirus-insect cell expression for vaccine development.
- Analysis of manufacturing scalability and cost-effectiveness.
Main Results:
- The system can produce a wide array of prophylactic and therapeutic vaccine candidates.
- Potential for low manufacturing costs and utilization of existing mammalian cell culture facilities.
- Enables rapid conversion for producing vaccines like pandemic influenza vaccines.
Conclusions:
- Baculovirus-insect cell expression systems provide a flexible and cost-effective platform for vaccine manufacturing.
- This technology can be deployed globally, including in regions lacking current vaccine production capabilities.
- The platform supports adaptable manufacturing strategies for diverse health priorities.
Related Concept Videos
01:09Recombinant DNA
Overview
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:18Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...